Original Research
The effects of diminazene aceturate on systemic blood pressure in clinically healthy adult dogs
Journal of the South African Veterinary Association | Vol 74, No 3 | a513 |
DOI: https://doi.org/10.4102/jsava.v74i3.513
| © 2003 K.E. Joubert, F. Kettner, R.G. Lobetti, D.M. Miller
| This work is licensed under CC Attribution 4.0
Submitted: 02 July 2003 | Published: 02 July 2003
Submitted: 02 July 2003 | Published: 02 July 2003
About the author(s)
K.E. Joubert,F. Kettner,
R.G. Lobetti,
D.M. Miller,
Full Text:
PDF (164KB)Abstract
Diminazene aceturate is a commonly used antibabesial agent. It has been postulated that diminazine may induce a decrease in blood pressure and exacerbate the hypotension presented in dogs with babesiosis. This study was undertaken to assess the effect of diminazine aceturate on the blood pressure of healthy dogs. Six healthy German shepherd dogs between 18 and 24 months of age with a mean weight of 30.4 ± 2.75 kg were used. Blood pressure was directly measured at the following time intervals: –5, 0, 5, 10, 15, 20, 25, 30, 35, 40, 50, 60, 90 and 120 minutes after treatment with diminazine aceturate (4.2 mg/kg) intramuscularly. No statistical difference (P > 0.05) was found in blood pressure between any of the time intervals. An increase in heart rate was seen 5 minutes after the administration of diminazine aceturate but no change in blood pressure was evident. This study concluded that diminazene aceturate in its current formulation with antipyrine does not alter blood pressure in healthy adult dogs.
Keywords
Antibabesial Drug; Babesia; Blood Pressure; Canine; Diamidines; Diminazene Aceturate
Metrics
Total abstract views: 2665Total article views: 4459
Crossref Citations
1. Angiotensin converting enzyme 2 and diminazene
Elena Velkoska, Sheila K. Patel, Louise M. Burrell
Current Opinion in Nephrology and Hypertension vol: 25 issue: 5 first page: 384 year: 2016
doi: 10.1097/MNH.0000000000000254